Resistance to Streptozotocin-Induced Autoimmune Diabetes in Absence of Complement C3: Myeloid-Derived Suppressor Cells Play a Role

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Gao, Xiaogang ^a   Liu, Huanhai ^a   He, Bin ^b   Fu, Zhiren ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; ARGININE; COMPLEMENT COMPONENT C3; INDUCIBLE NITRIC OXIDE SYNTHASE; STREPTOZOCIN; TRANSFORMING GROWTH FACTOR BETA; AUTACOID; CYTOKINE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DIABETES; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL COUNT; CONTROLLED STUDY; DISEASE RESISTANCE; FLOW CYTOMETRY; GENE EXPRESSION; HISTOPATHOLOGY; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PANCREAS; PATHOGENESIS; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; STREPTOZOCIN DIABETES; SUPPRESSOR CELL; T LYMPHOCYTE; ANIMAL; C57BL MOUSE; COCULTURE; DOWN REGULATION; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; MYELOID-DERIVED SUPPRESSOR CELL; PANCREAS ISLET; PATHOLOGY; TRANSGENIC MOUSE;

MUS;

ANIMALS; COCULTURE TECHNIQUES; COMPLEMENT C3; CYTOKINES; DIABETES MELLITUS, TYPE 1; DOWN-REGULATION; INFLAMMATION MEDIATORS; ISLETS OF LANGERHANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELOID-DERIVED SUPPRESSOR CELLS; STREPTOZOCIN;

EID: 84879186047     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066334     Document Type: Article

References (30)

1. Walport MJ, (2001) Complement. First of two parts. N Engl J Med 344: 1058-1066.
2. Duncan RC, Wijeyewickrema LC, Pike RN, (2008) The initiating proteases of the complement system: controlling the cleavage. Biochimie 90: 387-395.
3. Linton SM, Morgan BP, (1999) Complement activation and inhibition in experimental models of arthritis. Mol Immnuol 36: 905-914.
4. Hawlisch H, Wills-Karp M, Karp CL, Kohl J, (2004) The anaphylatoxins bridge innate and adaptive immune reponses in allergic asthma. Mol Immunol 41: 123-131.
5. Pritchard MT, McMullen MR, Stavitsky AB, Cohen JI, Lin F, et al. (2007) Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice. Gastroenterology 132: 1117-1126.
6. Berger SP, Daha MR, (2007) Complement in glomercular injury. Semin Immunopathol 29: 375-384.
7. Ffrench-Constant C, (1994) Pathogenesis of multiple sclerosis. Lancet 343: 271-275.
8. Li Q, Nacion K, Bu H, Lin F, (2009) The complement inhibitor FUT-175 suppresses T cell autoreactivity in experimental autoimmune encephalomyelitis. Am J Pathol 175: 661-667.
9. Lin M, Yin N, Murphy B, Medorf ME, Segerer S, et al. (2010) Immune cell-derived C3 is required for autoimmune diabetes induced by multiple low doses of streptozotocin. Diabetes 59: 2247-2252.
10. Liu J, Lin F, Strainic MG, An F, Miller RH, et al. (2008) IFN-γ and IL-17 production in experimental autoimmune encephalomyelitis depends on local APC-T cell complement production. J Immunol 180: 5882-5889.
11. Gao X, Liu H, Ding G, Wang Z, Fu H, et al. (2011) Complement C3 deficiency prevent against the onset of streptozotocin-induced autoimmune diabetes involving expansion of regulatory T cells. Clin Immunol 140: 236-243.
12. Berezhnaya NM, (2010) Interaction between tumor and immune system: the role of tumor cell biology. Exp Oncol 32: 159-166.
13. Cuenca AG, Delano MJ, Kelly-Scumpia KM, Moreno C, Scumpia PO, et al. (2011) A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma. Mol Med 17: 281-292.
14. Cripps JG, Gorham JD, (2011) MDSC in autoimmunity. Int Immunopharmacol 11: 789-793.
15. Bronte V, Serafini P, Santo CD, Marigo I, Tosello V, et al. (2003) IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice. J Immunol 170: 270-278.
16. Rodriguez PC, Zea AH, DeSalvo J, Culotta KS, Zabaleta J, et al. (2003) L-arginine consumption by macrophage modulates the expression of CD3ξ chain in T lymphocytes. J Immunol 17: 1232-1239.
17. Yin B, Ma G, Yen CY, Zhou Z, Wang GX, et al. (2010) Myeloid-derived suppressor cells prevent type 1 diabetes in murine models. J Immunol 185: 5828-5834.
18. Apetoh L, Vegran F, Ladoire S, Ghiringhelli F, (2011) Restoration of antitumor immunity through selective inhibition of myeloid-derived suppressor cells by anticancer therapies. Curr Mol Med 11: 365-372.
19. Rodriguez PC, Quiceno DG, Zabaleta J, Ortiz B, Zea AH, et al. (2004) Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res 64: 5839-5849.
20. Rodriguez PC, Hernandez CP, Quiceno DG, Dubinett SM, Zabaleta J, et al. (2005) Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma. J Exp Med 202: 931-939.
21. Yang L, Huang J, Ren X, Gorska AE, Chytil A, et al. (2008) Abrogation of TGF-β signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 13: 23-35.
22. Li H, Han Y, Guo Q, Zhang M, Cao X, (2009) Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-β1. J Immunol 182: 240-249.
23. Srivastava MK, Sinha P, Clements VK, Rodriguez P, Ostrand-Rosenberg S, (2010) Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Cancer Res 70: 68-77.
24. Hanson EM, Clements VK, Sinha P, Ilkovitch D, Ostrand-Rosenberg S, (2009) Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells. J Immunol 183: 937-944.
25. Hoechst B, Gamrekelashvili J, Manns MP, Greten TF, Korangy F, (2011) Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells. Blood 117: 6532-6541.
26. Hoechst B, Ormandy LA, Ballmaier M, Lehner F, Kruger C, et al. (2008) A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells. Gastroenterology 135: 234-243.
27. Morales JK, Kmieciak M, Knutson KL, Bear HD, Manjili MH, (2010) GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr-1- bone marrow progenitor cells into myeloid-derived suppressor cells. Breast Cancer Res Treat 123: 39-49.
28. Sinha P, Clements VK, Fulton AM, Ostrand-Rosenberg S, (2008) Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. Cancer Res 67: 4507-4513.
29. Lechner MG, Liebertz DJ, Epstein AL, (2010) Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J Immunol 185: 2273-2284.
30. Anderson MS, Bluestone JA, (2005) The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 23: 447-485.